IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas

K. Mihajluk
, C. Simms
, M. Reay
, P. A. Madureira
, A. Howarth
, P. Murray
, S. Nasser
, C. A. Duckworth
, D. M. Pritchard
, G. J. Pilkington
, R. Hill

Institute of Life Sciences and Healthcare

University of Liverpool

Research output: Contribution to journal › Article › peer-review

423 Downloads (Pure)

1 results

2019

Corrigendum to “IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.” [Cancer Lett. 458C (2019) 29–38]
Mihajluk, K., Simms, C., Reay, M., Madureira, P. A., Howarth, A., Murray, P., Nasser, S., Duckworth, C. A., Pritchard, D. M., Pilkington, G. J. & Hill, R., 8 Oct 2019, (Early online) In: Cancer Letters.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
File

198 Downloads (Pure)